Andrew Combs Net Worth & Insider Trades

Andrew Combs - EVP, Prelude Therapeutics Inc

As of April 4, 2022

What is Andrew Combs's Net Worth?

The current estimated net worth of Prelude Therapeutics Inc's EVP, Andrew Combs, is estimated to be about $1.24M . Andrew Combs owns about 268,380 units of Prelude Therapeutics Inc common stock. In the last 2 years at Prelude Therapeutics Inc, Andrew Combs has sold an estimated value of $0 worth.

What is Andrew Combs's Past Insider Trading?

Andrew Combs's largest purchase order was 8,000 units , worth over $94.88K on December 15, 2021. In total, Andrew Combs has made about 5 transactions over 2 years of their time at Prelude Therapeutics Inc. Andrew Combs usually trades in December, February, July, April and September, with the busiest year in 2022 and 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Andrew Combs's' Mailing Address?

  • Mailing address is C/o Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19803 DE

What are Prelude Therapeutics Inc's Past Insider Trades?

Prelude Therapeutics Inc's most recent insider trade came on June 1, 2022 by Laurent Chardonnet who bought 10,000 units worth $42.3K . In the last 2 years, insiders at Prelude Therapeutics Inc have sold an estimated value of $10.32M and bought an estimated value of $79.2M worth of shares. Insider trading is most common in April, June and September, with the busiest year in 2021. The most active traders at the company are David Mauro, Chief Medical Officer,  Deborah Morosini, EVP,  and Peggy Scherle, Chief Scientific Officer .

Prelude Therapeutics Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1